Wednesday, July 8, 2026

Drug profile · INN

xylose

xylose (XYLOSE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 1
Pipeline programs 0
News articles 0
Drug details — xylose
US status
approved
Class
Route
ORAL
Patents
1
Programs
0
Data quality
0.84

Quick answer

xylose (XYLOSE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN xylose
Brand XYLOSE
Route ORAL
Formulation POWDER

Approval history

Authority Status Date
FDA approved

Related patents

  1. US 9695223

    Engineered xylose transporters with reduced glucose inhibition

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is xylose?

xylose (XYLOSE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for xylose?

XYLOSE is a marketed brand name for xylose. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of xylose?

xylose has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.